Related Experiment Video
Updated: Jul 2, 2026

Culture Methods to Determine the Limit of Detection and Survival in Transport Media of Campylobacter Jejuni in Human Fecal Specimens
Published on: March 10, 2020
Campylobacter bacteremia: clinical features and factors associated with fatal outcome
Jérôme Pacanowski1, Valérie Lalande, Karine Lacombe
1Service des Maladies Infectieuses et Tropicales, Hôpital Saint-Antoine, Paris, France. jerome.pacanowski@sat.aphp.fr
Background:
Campylobacter bacteremia is uncommon. The influence of underlying conditions and of the impact of antibiotics on infection outcome are not known.
Methods:
From January 2000 through December 2004, 183 episodes of Campylobacter bacteremia were identified in 23 hospitals in the Paris, France, area. The medical records were reviewed. Characteristics of bacteremia due to Campylobacter fetus and to other Campylobacter species were compared. Logistic regression analysis was performed to identify risk factors for fatal outcome within 30 days.
Results:
Most affected patients were elderly or immunocompromised. C. fetus was the most commonly identified species (in 53% of patients). The main underlying conditions were liver disease (39%) and cancer (38%). The main clinical manifestations were diarrhea (33%) and skin infection (16%). Twenty-seven patients (15%) died within 30 days. Compared with patients with bacteremia due to other Campylobacter species, patients with C. fetus bacteremia were older (mean age, 69.5 years vs. 55.6 years; P = .001) and were more likely to have cellulitis (19% vs. 7%; P = .03), endovascular infection (13% vs. 1%; P = .007), or infection associated with a medical device (7% vs. 0%; P = .02). Independent risk factors for death were cancer (odds ratio [OR], 5.1; 95% confidence interval [CI], 1.2-20.8) and asymptomatic infection (OR, 6.7; 95% CI, 1.5-29.4) for C. fetus bacteremia, the absence of prescription of appropriate antibiotics (OR, 12.2; 95% CI, 0.9-157.5), and prescription of third-generation cephalosporins (OR, 10.2; 95% CI, 1.9-53.7) for bacteremia caused by other species.
Conclusions:
Campylobacter bacteremia occurs mainly in immunocompromised patients. Clinical features and risk factors of death differ by infection species.
Insights
Campylobacter bacteremia is rare, primarily affecting immunocompromised individuals. Risk factors for fatal outcomes, including specific bacterial species and antibiotic use, vary significantly.
Area of Science:
- Infectious Diseases
- Bacteriology
- Clinical Microbiology
Background:
- Campylobacter bacteremia is an uncommon bloodstream infection.
- The roles of underlying health conditions and antibiotic treatments in patient outcomes remain unclear.
Purpose of the Study:
- To investigate the clinical characteristics of Campylobacter bacteremia.
- To identify risk factors associated with mortality within 30 days.
- To compare outcomes between infections caused by Campylobacter fetus and other Campylobacter species.
Main Methods:
- A retrospective review of 183 episodes of Campylobacter bacteremia from January 2000 to December 2004 in 23 Paris hospitals.
- Comparison of patient demographics, underlying conditions, clinical manifestations, and species involved (C. fetus vs. others).
- Logistic regression analysis to determine independent risk factors for 30-day mortality.
Main Results:
- The majority of patients were elderly or immunocompromised, with liver disease (39%) and cancer (38%) as primary underlying conditions.
- C. fetus was the predominant species (53%), associated with older patients and higher rates of cellulitis, endovascular infection, and medical device infections.
- Independent risk factors for death included cancer and asymptomatic infection for C. fetus bacteremia, and lack of appropriate antibiotics or use of third-generation cephalosporins for other species.
Conclusions:
- Campylobacter bacteremia predominantly affects immunocompromised individuals.
- Clinical presentations and mortality risk factors are distinct based on the infecting Campylobacter species.
Related Concept Videos
Determinants of Bacterial Pathogenicity and Virulence
Bacterial Gastroenteritis
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Endocarditis II: Clinical Features of Infective Endocarditis
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
